FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

We encourage you to read the FDA article "FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize" for detailed information on GLP-1 products and medication shortages. Additionally, explore the FDA's Drug Shortages Database for updates on supply levels, manufacturing, and availability. This resource helps healthcare professionals and patients stay informed about efforts to stabilize drug supplies and maintain access to essential medications. Access the database for more information.